157 related articles for article (PubMed ID: 18551756)
1. Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
Fernandez T; Morgan T; Davis N; Klin A; Morris A; Farhi A; Lifton RP; State MW
Am J Hum Genet; 2008 Jun; 82(6):1385. PubMed ID: 18551756
[No Abstract] [Full Text] [Related]
2. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
Fernandez T; Morgan T; Davis N; Klin A; Morris A; Farhi A; Lifton RP; State MW
Am J Hum Genet; 2004 Jun; 74(6):1286-93. PubMed ID: 15106122
[TBL] [Abstract][Full Text] [Related]
3. Terminal 3p deletions in two families--correlation between molecular karyotype and phenotype.
Pohjola P; de Leeuw N; Penttinen M; Kääriäinen H
Am J Med Genet A; 2010 Feb; 152A(2):441-6. PubMed ID: 20101686
[TBL] [Abstract][Full Text] [Related]
4. FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions.
Dijkhuizen T; van Essen T; van der Vlies P; Verheij JB; Sikkema-Raddatz B; van der Veen AY; Gerssen-Schoorl KB; Buys CH; Kok K
Am J Med Genet A; 2006 Nov; 140(22):2482-7. PubMed ID: 17036314
[TBL] [Abstract][Full Text] [Related]
5. Disruption of contactin 4 in three subjects with autism spectrum disorder.
Roohi J; Montagna C; Tegay DH; Palmer LE; DeVincent C; Pomeroy JC; Christian SL; Nowak N; Hatchwell E
J Med Genet; 2009 Mar; 46(3):176-82. PubMed ID: 18349135
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a patient with 3p deletion syndrome and a review of the literature.
Fernandez TV; García-González IJ; Mason CE; Hernández-Zaragoza G; Ledezma-Rodríguez VC; Anguiano-Alvarez VM; E'Vega R; Gutiérrez-Angulo M; Maya ML; García-Bejarano HE; González-Cruz M; Barrios S; Atorga R; López-Cardona MG; Armendariz-Borunda J; State MW; Dávalos NO
Am J Med Genet A; 2008 Nov; 146A(21):2746-52. PubMed ID: 18837054
[TBL] [Abstract][Full Text] [Related]
7. Disruption of Contactin 4 in two subjects with autism in Chinese population.
Guo H; Xun G; Peng Y; Xiang X; Xiong Z; Zhang L; He Y; Xu X; Liu Y; Lu L; Long Z; Pan Q; Hu Z; Zhao J; Xia K
Gene; 2012 Sep; 505(2):201-5. PubMed ID: 22750301
[TBL] [Abstract][Full Text] [Related]
8. Contactin 4 as an autism susceptibility locus.
Cottrell CE; Bir N; Varga E; Alvarez CE; Bouyain S; Zernzach R; Thrush DL; Evans J; Trimarchi M; Butter EM; Cunningham D; Gastier-Foster JM; McBride KL; Herman GE
Autism Res; 2011 Jun; 4(3):189-99. PubMed ID: 21308999
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of the human neural cell adhesion molecule, CNTN4 (alias BIG-2).
Hansford LM; Smith SA; Haber M; Norris MD; Cheung B; Marshall GM
Cytogenet Genome Res; 2003; 101(1):17-23. PubMed ID: 14571131
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
[TBL] [Abstract][Full Text] [Related]
11. A de novo 1.9-Mb interstitial deletion of 3q13.2q13.31 in a girl with dysmorphic features, muscle hypotonia, and developmental delay.
Shimojima K; Saito K; Yamamoto T
Am J Med Genet A; 2009 Aug; 149A(8):1818-22. PubMed ID: 19610083
[No Abstract] [Full Text] [Related]
12. A novel splice variant of the cell adhesion molecule contactin 4 ( CNTN4) is mainly expressed in human brain.
Zeng L; Zhang C; Xu J; Ye X; Wu Q; Dai J; Ji C; Gu S; Xie Y; Mao Y
J Hum Genet; 2002; 47(9):497-9. PubMed ID: 12202991
[TBL] [Abstract][Full Text] [Related]
13. 2p16.3 microdeletion with partial deletion of the neurexin-1 gene in a female with developmental delays, short stature, and a congenital diaphragmatic hernia.
Bermudez-Wagner K; Jeng LJ; Slavotinek AM; Sanford EF
Clin Dysmorphol; 2013 Jan; 22(1):22-4. PubMed ID: 23207424
[No Abstract] [Full Text] [Related]
14. De novo intragenic deletion of the autism susceptibility candidate 2 (AUTS2) gene in a patient with developmental delay: a case report and literature review.
Jolley A; Corbett M; McGregor L; Waters W; Brown S; Nicholl J; Yu S
Am J Med Genet A; 2013 Jun; 161A(6):1508-12. PubMed ID: 23650183
[No Abstract] [Full Text] [Related]
15. Expanding the clinical phenotype at the 3q13.31 locus with a new case of microdeletion and first characterization of the reciprocal duplication.
Vuillaume ML; Delrue MA; Naudion S; Toutain J; Fergelot P; Arveiler B; Lacombe D; Rooryck C
Mol Genet Metab; 2013; 110(1-2):90-7. PubMed ID: 23920044
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental disorders associated with dosage imbalance of ZBTB20 correlate with the morbidity spectrum of ZBTB20 candidate target genes.
Rasmussen MB; Nielsen JV; Lourenço CM; Melo JB; Halgren C; Geraldi CV; Marques W; Rodrigues GR; Thomassen M; Bak M; Hansen C; Ferreira SI; Venâncio M; Henriksen KF; Lind-Thomsen A; Carreira IM; Jensen NA; Tommerup N
J Med Genet; 2014 Sep; 51(9):605-13. PubMed ID: 25062845
[TBL] [Abstract][Full Text] [Related]
17. A patient with a de-novo deletion 3p25.3 and features overlapping with Rubinstein-Taybi syndrome.
Czeschik JC; Albrecht B; Kayserili H; Kuechler A; Wagner N; Wieczorek D; Lüdecke HJ
Clin Dysmorphol; 2014 Apr; 23(2):67-70. PubMed ID: 24561647
[No Abstract] [Full Text] [Related]
18. A report of a new case of an interstitial deletion at 3p25.3 and expansion of the clinical phenotype.
Bownass L; Lunt P; Williams C; Woodbridge T; Ellis M; Scurr I
Clin Dysmorphol; 2014 Apr; 23(2):63-66. PubMed ID: 24561646
[No Abstract] [Full Text] [Related]
19. 3p interstitial deletion: novel case report and review.
Ţuţulan-Cunită AC; Papuc SM; Arghir A; Rötzer KM; Deshpande C; Lungeanu A; Budişteanu M
J Child Neurol; 2012 Aug; 27(8):1062-6. PubMed ID: 22290856
[TBL] [Abstract][Full Text] [Related]
20. The role of new genetic technology in investigating autism and developmental delay.
Shur N; Gunn S; Feit L; Oh AK; Yatchmink Y; Abuelo D
Med Health R I; 2011 May; 94(5):131, 134-7. PubMed ID: 21710921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
